0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

MANAGEMENT WITH PROCAINE AMIDE (PRONESTYL) OF PYLOROSPASM IN INFANTS

Max S. Sadove, M.D.; John L. Keeley, M.D.; James A. Rooney, M.D.; Anthony Guzauskas, M.D.
JAMA. 1954;154(16):1328-1330. doi:10.1001/jama.1954.02940500008003.
Text Size: A A A
Published online

Procaine amide (Pronestyl) was synthesized in 1949 in the course of a search for a drug similar in action to procaine. It was desirable that the drug be longer acting and cause less nervous system stimulation and less vasomotor depression. Procaine amide was found to have these advantages. The published data described its use in the treatment of cardiac irregularities, principally ventricular arrhythmias.1 One of us (M. S. S.) has been making clinical studies of procaine and procaine amide given orally in the treatment of such conditions as arthritis, causalgia, vasospasm, pruritis, pain, and hiccup. Because of the advantages of procaine amide listed above, it was substituted for procaine in these studies of oral administration. It occurred to us that procaine amide administered orally should be given a clinical trial in spastic and related conditions of the upper alimentary tract instead of procaine, which was used in the studies

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();